Loading...
Indian Pharmaceutical Exporter · #5 for Caffeine · $4.0M export value · DGFT Verified
Medreich Limited is the #5 Indian exporter of Caffeine with $4.0M in export value and 133 verified shipments. Medreich Limited holds a 3.7% market share in Caffeine exports across 5 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
| 1 |
| 0.4% |
Medreich Limited exports Caffeine to 5 countries. The largest destination is FRANCE accounting for 92.9% of Medreich Limited's Caffeine shipments, followed by NIGERIA (4.3%) and AUSTRALIA (1.7%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SANOFI AVENTIS | FRANCE | $1.2M | 55 |
| DHL SERVICES LOGISTIQUES | FRANCE | $1.1M | 21 |
| TRIDEM PHARMA | FRANCE | $738.8K | 32 |
| TRIDEM PHARMA.., | FRANCE | $307.6K | 7 |
| SANOFI-AVENTIS NIGERIA LIMITED | NIGERIA | $90.5K | 3 |
| TRIDEM PHARMA.. | FRANCE | $65.0K | 2 |
| SANOFI AVENTIS NIGERIA LTD | NIGERIA | $63.0K | 2 |
| MEDREICH AUSTRALIA PTY LTD | AUSTRALIA | $62.0K | 9 |
| OQCORP S A C | PERU | $25.4K | 1 |
| AL-JABER PHARMA FOR DRUGS&MEDICAL | YEMEN, DEMOCRATIC | $15.3K | 1 |
Medreich Limited supplies Caffeine to 10 buyers globally. The largest buyer is SANOFI AVENTIS (FRANCE), followed by DHL SERVICES LOGISTIQUES (FRANCE) and TRIDEM PHARMA (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $61.8M worth of Caffeine through 6,464 shipments from 471 suppliers to 122 countries, serving 916 buyers globally. Medreich Limited contributes $4.0M to this total, accounting for 3.7% of India's Caffeine exports. Medreich Limited ships Caffeine to 5 countries through 10 buyers.
Medreich Limited's average Caffeine shipment value is $30.2K per consignment, based on 133 shipments totaling $4.0M. The largest destination is FRANCE (92.9% of Medreich Limited's Caffeine exports).
Medreich Limited ranks #5 among 471 Indian Caffeine exporters with a 3.7% market share. The top 3 exporters are ADCOCK INGRAM LIMITED ($22.3M), SOCOMED PHARMA PRIVATE LIMITED ($9.6M), RONAK EXIM PRIVATE LTD ($4.9M). Medreich Limited processed 133 shipments to 5 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PARACETAMOL IBUPROFEN AND CAFFEINE CAPSU | $153.6K | 5 |
| PARACETAMOL 325mg,IBUPROFEN 200mg AND CAFFEINE 30mgCAPSULES (IBEX CAPSULES) 2X12S (161875 PACKS) | $100.0K | 2 |
| IBUPROFEN 200MG+PARACETAMOL 325MG+CAFFEINE 30MG (TRIALGIC CAPSULES) 2X12S (96448PACKS) | $86.3K | 2 |
| IBUPROFEN 200MG+PARACETAMOL 325MG+CAFFEINE 30MG (TRIALGIC CAPSULES) 2X12S (144128 PACKS) | $64.9K | 3 |
| PARACETAMOL 325MGIBUPROFEN 200MG AND CAFFEINE 30MG CAPSULES (IBEX CAPSULES) 2X12S (162029 PACKS)NOS | $64.8K | 3 |
| PARACETAMOL 325MG,IBUPROFEN 200MG AND CAFFEINE 30MG CAPSULES (IBEX CAPSULES) 2X12S (160650 PACKS)NOS | $64.3K | 3 |
| PARACETAMOL 325MG,IBUPROFEN 200MG AND CAFFEINE 30MG CAPSULES (IBEX CAPSULES) 2X12S (160195 PACKS) | $64.1K | 3 |
| PARACETAMOL 325MG,IBUPROFEN 200MG AND CAFFEINE 30MG CAPSULES (IBEX CAPSULES)- 830430 2X12S ( 159908 PACKS ) | $64.0K | 3 |
| PARACETAMOL 325MG,IBUPROFEN 200MG AND CAFFEINE 30MG CAPSULES (IBEX CAPSULES) 2X12S (159747 PACKS) | $63.9K | 3 |
| IBUPROFEN 200MG PARACETAMOL 325MG CAFFEINE30MG TRIALGICCAPSULES 2X12S 48000 PACKS | $54.5K | 2 |
Medreich Limited exports 84 distinct Caffeine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PARACETAMOL IBUPROFEN AND CAFFEINE CAPSU with 5 shipments worth $153.6K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
What Medreich Limited must comply with to export Caffeine to its top destination countries
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | RONAK EXIM PRIVATE LTD | $4.9M | 350 | 6 | $14.0K |
| 4 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $4.6M | 519 | 2 | $8.8K |
| 5 | MEDREICH LIMITED ★ | $4.0M | 133 | 5 | $30.2K |
| 6 | LABORATE PHARMACEUTICALS INDIA LTD | $3.7M | 87 | 8 | $43.0K |
| 7 | BASE PHARMACY (INDIA) | $2.1M | 43 | 2 | $50.0K |
Medreich Limited ranks #5 among 471 Indian Caffeine exporters. Average shipment value of $30.2K compared to the market average of $131.3K. The closest competitors by value are RONAK EXIM PRIVATE LTD and J B CHEMICALS AND PHARMACEUTICALS LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| JNPT/ NHAVA SHEVA SEA | 948 | 14.7% |
| NHAVA SHEVA SEA (INNSA1) | 687 | 10.6% |
| JNPT | 660 | 10.2% |
| BANGALORE ICD | 547 | 8.5% |
| NHAVA SHEVA | 327 | 5.1% |
| AHEMDABAD ICD | 262 | 4.1% |
| MUNDRA SEA | 262 | 4.1% |
| NHAVA SHEVA SEA | 194 | 3.0% |
Visual overview of India's caffeine supplier profile for Medreich Limited — top suppliers, destinations, pricing, and trade routes
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
Medreich Limited exports 42 products worth $224.8M. Beyond Caffeine, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Caffeine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 916+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Caffeine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Caffeine. For current shipment-level data, contact TransData Nexus.